moroctocog alfa
UkraineDrugs containing this active substance
-
The drug is intended for the treatment and prevention of bleeding in patients with hemophilia A (congenital deficiency of coagulation factor VIII). It is suitable for adults and children of any age, including infants.
Form: lyophilisate for solution for injection
Active substance Dosage moroctocog alfa 250 IU ATC: B02BD02
-
The drug is used for the treatment and prevention of bleeding in patients with hemophilia A (congenital deficiency of clotting factor VIII). It is suitable for adults and children of any age.
Form: lyophilisate for solution for injection
Active substance Dosage moroctocog alfa 500 IU ATC: B02BD02
-
The drug is used for the treatment and prevention of bleeding in patients with hemophilia A (congenital deficiency of coagulation factor VIII). It is intended for both adults and children of any age.
Form: lyophilisate for solution for injection
Active substance Dosage moroctocog alfa 1000 IU ATC: B02BD02
-
The drug is used for the treatment and prevention of bleeding in patients with hemophilia A (congenital deficiency of clotting factor VIII). It is suitable for adults and children of any age, including infants.
Form: lyophilisate for solution for injection
Active substance Dosage moroctocog alfa 2000 IU ATC: B02BD02
-
The drug is used for the treatment and prevention of bleeding in patients with hemophilia A (congenital deficiency of clotting factor VIII). It is suitable for adults and children of any age.
Form: lyophilisate for solution for injection
Active substance Dosage moroctocog alfa 3000 IU ATC: B02BD02
Manufacturer: Vait Pharma S.A. (quality control at batch release and stability testing, labeling, secondary packaging, batch release)